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Background: Smoking prevalence rates among the lesbian, gay, bisexual, and transgender (LGBT) population are
significantly higher than the general population. However, there is limited research on smoking cessation treatments in
this group, particularly on culturally targeted interventions. Moreover, there are few interventions that address culturally
specific psychosocial variables (e.g., minority stress) that may influence outcomes. This paper describes the protocol for
a comparative effectiveness trial testing an evidence-based smoking cessation program, Courage to Quit, against a
culturally tailored version for LGBT smokers, and examines the role of culturally specific psychosocial variables
on cessation outcomes.
Methods/Design: To examine the effectiveness of a culturally targeted versus standard smoking cessation
intervention, the study utilizes a 2-arm block, randomized, control trial (RCT) design. Adult LGBT participants (n = 400)
are randomized to one of the two programs each consisting of a six-session group program delivered in a community
center and an eight week supply of the transdermal nicotine patch. Four individualized telephone counseling sessions
occur at weeks 2, 5, 7, and 9, at times of greatest risk for relapse. Study outcome measures are collected at baseline,
and 1, 3, 6, and 12 months post quit date. Primary outcomes are expired air carbon monoxide verified 7-day
point-prevalence quit rates at each measurement period. Secondary outcomes assess changes in cravings,
withdrawal symptoms, smoking cessation self-efficacy, and treatment adherence. Additionally, study staff examines
the role of culturally specific psychosocial variables on cessation outcomes using path analysis.
Discussion: Determining the efficacy of culturally specific versus standard evidence based approaches to smoking
cessation is a critical issue facing the field today. This study provides a model for the development and implementation
of a culturally tailored smoking cessation intervention for LGBT participants and addresses a gap in the field by
examining the role of culturally psychosocial variables associated with cessation outcomes.
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Significance
In 2010, an estimated 25.2% of U.S. adults were current
tobacco users, with 19.5% of adults reporting current
cigarette smoking (King et al. 2012). However, the preva-
lence of smoking varies substantially by sexual orientation,
with LGBT respondents significantly more likely to report
cigarette smoking (32.8%) and cigar/cigarillo smoking
(12.2%) than heterosexual respondents (19.5%; 6.5%)
(King et al. 2012). Further, LGBT youth report higher
past-30 day cigarette use (bisexual = 27.5% and lesbian/
gay = 34.8%) compared with heterosexual youth (18.5%)
(Rath et al. 2013). Although data are not currently
available on cancer rates among LGBT smokers (Bowen
and Boehmer 2007), morbidity and mortality due to
tobacco use may be higher due to a greater prevalence
of risk factors (e.g., heavy drinking and obesity) for
diseases exacerbated by smoking (e.g., heart disease,
diabetes, certain cancers, and HIV/AIDS) (Aaron et al.
2001). Despite both elevated smoking prevalence rates
and increased vulnerability for smoking-related health
disparities, few clinical trials of smoking cessation in-
terventions for LGBT people exist (Hutchinson et al.
2006). Further, the Institute of Medicine report on
LGBT health (Institute of Medicine of the National
Academies 2011) failed to provide comprehensive goals
to address this disparity. As such, LGBT smokers repre-
sent an important and underserved priority group for
cessation efforts.
Smoking cessation and LGBT populations
Research has shown that psychosocial variables related
to smoking cessation may differ among subgroups (Fiore
et al. 2008) and that considering cultural variation improves
substance abuse treatment outcomes (Perez-Arce et al.
1993). A recent report by the Surgeon General highlights
the need for additional research to determine whether
tobacco dependence treatment programs have similar
efficacy across diverse subgroups (U.S. Department of
Health and Human Services 2000). Although research
has identified differential cessation treatment needs of
some groups (e.g., African Americans and women), we
do not yet have precise data on the outcomes of LGBT
smokers in mainstream smoking cessation interventions
(Greenwood et al. 2005).
To date, there are few smoking cessation trials focused
on LGBT smokers. The majority of the available studies
are minimally tailored group based interventions delivered
in community-based settings (Dickson-Spillmann et al.
2014; Eliason et al. 2012; Harding et al. 2004; Matthews
et al. 2013a; Matthews et al. 2013b; Walls and Wisneski
2011). Although initial results are promising with end of
treatment quit rates comparable to or better than those
reported in the literature for smoking cessation programsin non-LGBT samples, there are concerns about the wide
range in outcomes (16%-73% quit rates), small sample
sizes, the absence of control groups, and the lack of
objective verification of self-reported quit rates. Direct
comparisons of interventions between LGBT and non-
LGBT populations on non-tailored treatments are also
limited. One intensive cessation intervention that was
designed for the general population and combined bupro-
pion, individual counseling, and nicotine replacement
therapy found no significant difference in end of treatment
quit rates for heterosexual and gay/bisexual male partici-
pants (57% vs. 58%, respectively) (Covey et al. 2009). As
such, more extensive research is needed to determine
the efficacy of smoking cessation interventions for LGBT
populations.
Consideration of LGBT related psychosocial factors
Compounding the modest intervention effects, there are
large knowledge gaps regarding predicators of LGBT
smoking cessation. In the general population, smoking
cessation is strongly influenced by individually mediated
predictors, including perceived benefits and barriers,
self-efficacy, stage of readiness, and treatment adherence
(Link et al. 2001; Spencer et al. 2002). Specific cultural
factors (i.e., salience and identification with LGBT identity)
are likely to play a role in smoking behaviors (Meyer 2003).
Additionally, LGBT smokers are exposed to unique psy-
chosocial stressors likely to influence smoking behaviors,
such as elevated general stress (i.e., level of stress and num-
ber of stressful life events) and minority specific stress (i.e.,
internalized homophobia, sexual orientation conceal-
ment, discrimination events, stigma consciousness) (Meyer
2003; Steptoe et al. 1996; Rostosky et al. 2007). Minority
stress (i.e., stress resulting from belonging to a stigmatized
social category over and above general life stress; Meyer
2003) has been highlighted as an important but under-
researched psychosocial influence on LGBT risk behaviors
(Cochran and Mays 2000). As applied to LGBT individuals,
minority stress is composed of five factors: (1) experiences
of discrimination and violence, (2) stigma consciousness
(awareness of discrimination), (3) sexual orientation con-
cealment (level of ‘outness’), and (4) internalized homo-
phobia (direction of societal negative attitudes toward
the self ) (Meyer, 2003). Presumed antecedents to minority
stress (e.g., token minority status) have been used to
explain mental and physical health outcomes in diverse
samples (Clark et al. 1999). Further, minority stress for
LGBT individuals has been associated with lower job
satisfaction, increased distress and health related problems
(Cochran and Mays 2000; Clark et al. 1999). However, we
are not aware of any published studies that have used the
minority stress framework to guide the development of a
targeted risk reduction intervention. Given the strong and
positive relationships between stress and/or negative affect
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is a highly plausible heuristic for exploring predictors of
smoking cessation outcomes in LGBT individuals. Thus,
more research is needed to examine culturally specific
individual mediators of cessation for LGBT smokers,
including salience and identification with LGBT identity
and community, general stress, and minority specific
stress related to LGBT identity.
The present study
This study addresses an important gap in the literature
by examining the effectiveness of a culturally targeted
LGBT smoking cessation intervention in a randomized
control trial. Additionally, we aim to examine the influence
of LGBT specific cultural factors on smoking cessation.
Our conceptual model is based on an integration of the
core constructs of the Transtheoretical Model (TTM;
Prochaska and Velicer 1998) and the Health Belief Model
(HBM); (Becker et al. 1977) and emphasizes the multidi-
mensional nature of health behavior change. In our model
(see Figure 1), we posit behavior change is incremental in
nature, shaped by health beliefs (as specified by the HBM),
and associated with distinct stages (as in the TTM). In our
intervention, we target individually mediated predictors of
cessation at each stage of behavior change, including treat-
ment adherence. This approach was used successfully in
smoking cessation, mammography screening, nutritional
intake, and exercise behavior (Campbell et al. 1994;
Longshore and Grills 2000; Resnicow et al. 2001; Skinner
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Figure 1 Proposed smoking behavior change conceptual framework.The primary comparison in this study is between the cul-
turally targeted (CTQ-CT) versus a standard Respiratory
Health Association of Metropolitan Chicago’s (RHA)
“Courage to Quit (CTQ)”, non-targeted program. How-
ever, our model also provides a framework to understand
how the CTQ-CT affects smoking behavior, as well as the
mediating or moderating factors that influence outcomes.
Although most health behavior change models have been
critiqued for not including a cultural component, our
model incorporates psychosocial and cultural factors (e.g.,
minority stress) unique to the LGBT population along
with generic predictors of cessation.
Specific aims
The primary aim of this study is to examine the efficacy of
culturally targeted CTQ-CT smoking cessation intervention
compared to the standard CTQ program, in conjunction
with nicotine replacement and peer support, for smoking
cessation in LGBT smokers over time. Secondary aims are
to determine the relationships of the cultural (i.e., identifi-
cation with LGBT community and salience of sexual orien-
tation identity) and psychosocial (i.e., indicators of general
and minority stress) factors on smoking cessation outcomes
using path analysis. Our primary hypothesis tests whether
quit rates will be higher among individuals randomized to
receive the CTQ-CT versus those who receive the standard
CTQ program. We further hypothesize that higher levels
of general and minority specific stress may be related to
worse outcomes in smoking quit rates and these effects
are moderated by treatment type.eristics*
Smoking Cessation Outcomes
Quit outcomes:

























Note: *Intervened on in the CTQ intervention.
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Study design
A prospective 2-group randomized experimental design is
proposed to test study hypothesizes related to the added
benefit of the culturally tailored CTQ program (CTQ-CT)
versus the standard CTQ program. The primary smoking
cessation outcome examines point prevalence abstinence
(i.e., no smoking, not even a puff, for previous 7 days). To
determine short and longer-term cessation outcomes, self-
report outcomes are objectively verified (using carbon
monoxide [CO] testing) at 1 month, 3, 6, and 12 month
follow-up time points. For an overview of the RCT study
design, see Figure 2. Study activities have been reviewed
and approved by the institutional review boards of The





















Figure 2 Illustration of RCT study design and participant flowchart.number 2010–0538) and the Howard Brown Health
Center (protocol identification number 10-163-100) com-
munity partner.
Recruitment and retention
Participants will be 400 (200 CTQ-CT and 200 CTQ)
LGBT tobacco smokers recruited from the community.
This project is housed in the Behavioral Research De-
partment of Howard Brown Health Center (HBHC), our
community partner. Howard Brown Health Center is a
nationally known LGBT health organization with a thirty-
year history of conducting LGBT behavioral research.
Recruitment takes place at HBHC through flyers about
the study, information provided by clinic staff, and vol-
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and venue locations, including bars, clubs, circuit parties,
festivals, gyms, gay businesses, and other locations where
LGBT socialize or congregate. Passive community out-
reach includes flyers, referrals, word of mouth, and posted
advertisement on email listservs and websites, including
social media sites. Participants are considered eligible if
they: 1) self-identify as lesbian, gay, bisexual, or trans-
gender, 2) are ages 18–65, 3) are current cigarette smokers
(more than 5 packs in lifetime AND past year smoking
AND 4 or more days per week AND CO air expired read-
ing of ≥8 ppm), 4) express a desire to quit smoking (at
least a 5 on a 10-point Likert scale), 5) agree to attend
behavioral counseling sessions, be randomized, and be
followed-up with, 6) agree to use nicotine patch and
have no prior adverse reactions to patches, and 7) have a
stable residence and telephone. Readiness and motivation
to quit are key inclusion criteria. Research assistants offer
self-help manuals to the less motivated (<5 on desire to
quit smoking scale) and encourage them to attend the
program at a more appropriate time.
Our goal is to achieve an 80% retention rate or better
over the study period. Retention activities include pro-
viding incentives at each data collection point, providing
a bonus incentive (lotteries) for those who complete all
data collection points, providing giveaways such as pens
with the study logo on them, sending birthday and holi-
day cards, and training staff on participant engagement
and retention.
Accrual and enrollment
A dedicated research phone line at the HBHC is used
to enroll participants. Trained research assistants (RAs)
answer calls, explain the study and assess eligibility for
participation. The screening interview is a 10–15 minute
semi-structured list of background characteristics, contact
information, general medical condition, medications, and
brief questions on smoking history. Eligible and interested
individuals are given an appointment time at HBHC for
an in-person screening with a study RA. At the first meet-
ing, all participants sign informed consents, complete
baseline measures, and receive an initial packet of study
materials. Participants also meet with the study medical
provider for a general health screening to evaluate any
contraindications for nicotine replacement. Baseline mea-
sures are completed on a laptop computer in both an
interviewer-administered and self-administered format.
Randomization
Participants are randomized to CTQ-CT or non-targeted
CTQ groups after eligibility and baseline screenings. The
study statistician conducts the permuted-block random-
ization using a software program developed by program-
mers at UIC. This program uses random digits to assigncode numbers in random blocks of equal control and
experimental subject assignments. The study statistician
place the results of the assignments in sealed, solid enve-
lopes. All study participants are blinded and retain no
knowledge of CTQ or CTQ-CT group assignment.Power analysis
Sample size and power for the study are based on detect-
ing a 20% significant difference in cessation rates between
the CTQ-CT and CTQ group in cross-sectional multi-
nomial logistic regression models, in longitudinal survival
analyses and in structural equation models. The logistic
regression of smoking cessation on a continuous, normally
distributed variable (e.g., perceived barriers) with a sample
size of 340 observations achieves 85% power at 0.05 to
detect the probability of change from the value of 0.05
at the mean of 0.16 when it is increased to one stand-
ard deviation above the mean. This change corresponds
to an odds ratio of .40 (with an adjustment other inde-
pendent variables explaining 20% of the variance)
(Hsieh et al. 1998). Thus, approximately 400 subjects
are required to provide a sample size of 340 partici-
pants for the survival analyses. Finally, in addition to
sample size, the power for estimating and testing struc-
tural equation models depends on the numbers of free
parameters and observed variables in each model (Saris
and Satorra 1993). Sample sizes of 200–300 are generally
regarded as effective in most cases for assessing model
fit at an alpha of .05 (Boomsma 1982; Hoelter 1983;
Schumacker and Lomax 1996); with 340 participants we
will have adequate power to detect close-fitting models
with 12 or more df, including tests of mediation (i.e.,
program and NRT adherence and treatment outcomes).Procedures
Participants are enrolled on a continuous basis. Behavioral
counseling consists of six weekly 90-minute smoking
cessation therapy sessions commencing two weeks before
the quit date. Each session is preceded by a short interview
with a research assistant to obtain self-report psychosocial
and substance use information, obtain carbon monoxide
measures, and distribute nicotine replacement. Nicotine
replacement use begins on the quit date and continue
for eight weeks. Post treatment follow-up interviews
take place in person at 1, 3, 6, and 12 months after the
quit date. These ½ -1 hour follow-up sessions with the
research assistant include subjective questionnaires
and objective measures (CO). For participants unable
to complete interview in person at HBHC, 1, 3, 6, and
12 month follow-up assessments are completed remotely,
over the phone. Research assistants collecting participant
measures during follow-up interviews are blinded to treat-
ment condition.
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All participants are evaluated by the study medical pro-
vider to determine the appropriateness of nicotine replace-
ment use (i.e., Nicoderm CQ: GlaxoSmithKline Consumer
Healthcare, Pittsburgh, PA). At each visit, study staff
distributes nicotine replacement therapy for each par-
ticipant. An extra supply of three patches is given at
each interval as back-ups if patches fall off, get misplaced,
or if the subject does not attend the next session and
needs an interim supply. Standard patch instructions
are provided to each participant. Per manufacturer’s
instructions for dosage, if a participant smokes 10 or
more cigarettes per day, the initial dose is 21 mg for
four weeks, 14 mg for two weeks, and then 7 mg for
the final two weeks. Modifications of dosing level are
adjusted, as needed, in conjunction with study medical
provider in individuals who experience a substantial decline
in smoking levels over the first two weeks in treatment
(estimated at <10% of the sample) or who were lighter
smokers at baseline.
Intervention counselor training
A professional and a lay counselor who identify as LGBT
facilitate each smoking cessation group. Both professional
and lay counselors provide telephone support between
sessions, as requested by participants. Process data (e.g.,
length and frequency of additional support contacts) is
collected. The study primary investigator (A.M., clinical
psychologist) takes primary responsibility of the training
and supervision of counselors for the CTQ-CT and the
CTQ program. To reduce contamination effects based
on counselor training, group based supervision takes
place on a monthly basis. Peer-support training is based
on an established training model (Johnson et al. 2005).
Former LGBT smokers serve as peer support staff
(n = 6; Koehinger et al. 2005) and are trained in 4 weekly
60-minute sessions that cover: 1) cognitive/behavioral
approaches used in the CTQ program, 2) smoking related
health information, 3) motivational interviewing tech-
niques, 4) strategies for eliciting and addressing barriers
to smoking cessation for LGBT persons, 5) roles and
responsibilities of peer support persons, 6) participant
confidentiality, 7) helping participants deal with smoking
triggers, cravings and lapses, 8) listening and feedback
skills, and 9) providing non-judgmental support. Group
leaders complete pre and post-measures to assess effect-
iveness of the peer support training. Ten percent of group
sessions are audiotaped and reviewed by an independent
rater for fidelity checks.
Courage to quit smoking cessation treatment program
The Courage to Quit® (CTQ) program (developed by
A.K.) was first implemented in 2008 by the Respiratory
Health Association of Chicago (RHA) in partnership withcommunity agencies with the goal of reaching under-
served, minority, and low income smokers. The program
is given at no- or low-cost (nominal fees for materials)
and sessions are conducted in community health cen-
ters, non-profit organizations, faith-based organizations
(e.g., churches), housing programs, hospitals, substance
abuse treatment centers, and academic institutions.
Group sizes average 10–20 participants. The first five
sessions are held weekly. The third week is the target
quit date, followed by the fourth (one week later), fifth
(one week after session four), and the sixth (two weeks
later) sessions. The program has been used as a platform
treatment in clinical trials with six-month biochemically
confirmed point-prevalence quit rates ranging from
19–35% (King et al. 2006, 2012; Matthews et al. 2009).
The treatment modules include a progression of topics
incorporating evidence-based behavioral, cognitive, and
motivational smoking cessation strategies as outlined in the
U.S. Public Health Service Clinical Practice Guidelines for
Treating Tobacco Use and Dependence (Fiore et al. 2008).
Each session of the CTQ program has a particular em-
phasis. Group participation is encouraged in session one,
which focuses on health benefits and relaxation techniques.
Session two emphasizes motivation and covers nicotine
addiction and peer support. Session three (quit week)
provides testimonies of ex-smokers, offering hope that
quitting is possible. Information on nicotine replacement
and symptoms of recovery (withdrawal symptoms) is
given, and participants commit to quit smoking for two
days. Session four focuses on benefits of cessation and
covers recovery symptoms and the grief process. Session
five emphasizes beginning a new life as a nonsmoker:
long-term goal setting, planning for social and stressful
situations and weight management concerns are discussed.
Session six introduces assertive communication tools and
exercise as a long-term maintenance strategy. The final
session recaps the program, discusses relapse prevention,
and includes a group celebration of their new lifestyle.
Group members who miss a session receive follow-up
from the group facilitator before the next session. Individ-
ual or small-group make-up sessions are conducted so that
all participants receive the full intervention content.
Culturally tailored courage to quit program (CTQ-CT)
The five strategies outlined by Kreuter et al. (2002) are
used to target the CTQ program to be culturally relevant
to LGBT smokers: (1) peripheral strategies (e.g., culturally
appropriate packaging, including images and exemplars
with LGBT individuals); (2) evidential strategies (e.g.,
enhancing perceived relevance by presenting evidence
of impact of smoking on LGBT); (3) linguistic strategies
(e.g., using language relevant to the LGBT community);
(4) constituent-involving strategies (e.g., including facil-
itators and peer support ‘buddies’ who are LGBT); and
Matthews et al. BMC Psychology 2014, 2:12 Page 7 of 11
http://www.biomedcentral.com/2050-7283/2/12(5) sociocultural strategies (e.g., discussing smoking-
related risks within the context of the broader social
and cultural values of LGBT).
The control condition is the standard CTQ program.
Professional and lay counselors are culturally sensitive.
Control group participants complete the same measures
and procedures as the CTQ-CT group members, including
the follow-up schedule and peer support. Peer support
telephone sessions take place at intervals of highest anxiety
of anticipated quitting (week 2) and greatest risk for early
relapse (weeks, 5, 7 and 9). (See Table 1 for overview of
session topics).
Measures
Table 2 shows the measures and time points for assess-
ments. Baseline measures include demographics (including
self-reported same and opposite-sex attraction; Diamond
2000), depressive symptoms (Beck et al. 1961), nicotine
dependence (Heatherton et al. 1991), alcohol dependence
(Selzer 1971), and expired-air carbon monoxide.
Smoking cessation outcomes are measured using mul-
tiple definitions of quit rates (Hughes et al. 2003; Hughes
and Hatsukami 1986): point prevalence smoking quit
rates (i.e., no smoking during the past seven days; de-
rived from Time Line Follow-Back interviews; Sobell
and Sobel 1995; Sobell et al. 1979); continuous abstinence
(i.e., abstinence period that began on quit date); prolonged
abstinence (i.e., no smoking in the past 30 days); and




Welcome participants, answer questions about the pr
assess readiness to quit encourage group participatio
Focus on group support. Discuss health benefits, des
models of nicotine addiction, focus on motivation fo
discuss nicotine replacement uses and function.
Session 2 Focus on factors leading to smoking, stress reduction
management, encourage peer one-on-one support
and social support.
Session 3 Quit week, nicotine replacement therapy (NRT), offer
that quitting is possible, provide information on NRT,
symptoms of recovery (withdrawal), participants com
a quit smoking attempt.
Session 4 Focus on barriers and facilitators to cessation. Discuss
symptoms, relapse prevention, weight management
and the grief process.
Session 5 Focus on goal setting and skill building. Discuss long
goal setting, planning for social and stressful situation
Session break
Session 6 Recap the program and review challenges of previou
Focus on long-term maintenance. Introduce anger m
tools, discuss relapse prevention, and celebrate newair carbon monoxide at each study visit and follow-up ses-
sion (Smokerlyzer, Bedfont Corp., Medford, NJ). Add-
itional smoking cessation outcomes include: withdrawal
symptoms (Hughes and Hatsukami, 1986); urges to smoke
(Cox et al. 2001); and temporal measures of consumption
and fluctuations in use patterns over time for cigarettes
and alcohol (derived from the Modified Time-Line Follow
Back Interview; Sobell and Sobel 1995; Sobell et al. 1979).
This range of outcomes may provide clues as to the mech-
anism of action of targeted interventions on smoking
(Hughes et al. 2003).
Individually mediated predictors of cessation are be
assessed using: perceived benefits, perceived barriers, and
self-efficacy of quitting (Health Belief Model Constructs,
Becker et al. 1977; Smoking Abstinence Self-Efficacy Scale,
Velicer et al. 1990); stage of readiness for smoking cessa-
tion (Prochaska and Velicer 1998); extent of considering
quitting (Biener and Abrams 1991); adherence to the nico-
tine replacement therapy and side effects (derived from
the Timeline follow-up interviews, daily participant logs,
and weekly patch counts; Ahluwalia et al. 1998).
Study participants complete a number of cultural and
psychosocial variables. First, level of identification with
the LGBT community (Bowen et al. 2006) is assessed.
Second, minority specific stress is measured using: internal-
ized homophobia (Herek et al. 1997); stigma consciousness
(adapted from Link 1987; Link et al. 2001); experience
of discrimination and sexual-minority related stressors
(Krieger et al. 2005); and sexual orientation concealmentCTQ-CT
ogram,
n.
CTQ Orientation. Discussion of general and culturally specific




CTQ Session 1. Discussion of LGBT health, teach relaxation
techniques
CTQ Session 2. Discussion of study development phase
outcomes, focus on LGBT specific factors of smoking
uptake and triggers, discussion of additional support




CTQ Session 3. Provide testimonies of ex-smokers,
craving and withdrawal management.
recovery
concerns
CTQ Session 4. Discussion of LGBT related health and




CTQ Session 5. Review of relapse causes and prevention,





CTQ Session 6. Review of study development phase
testimonies.
Table 2 Summary of study measures
Study variables Assessment point Measurement scale Reference
Smoking cessation outcomes: quit rates and smoking related outcomes
Biochemical verification
of smoking status
All time points Expired air CO breath test, α = .81,
sensitivity of 78%, specificity of 91%
Smokerlyzer, Bedfort Corp., NJ
Point prevalence smoking
quit rates
All time points Time-Line Follow Back (TLFB) interview, α = .80 Sobell and Sobel 1995;
Sobell et al. 1979
Smoking use patterns All time points Time-Line Follow Back (TLFB) interview, α = .80 Sobell and Sobel 1995;
Sobell et al. 1979
Withdrawal symptoms All time points Minnesota Nicotine Withdrawal Scale, 8-items,
α = .80-.85
Hughes and Hatsukami 1986
Smoking urges All time points Brief Questionnaire of Smoking Urges, 10-items,
α = .89
Cox et al. 2001; Tiffany
and Drobes, 1991
Individually mediated predictors of cessation
Perceived benefits Baseline, 3 and 6 mo. Perceived positive outcomes associated with quitting,
α = .70.
Menon et al. 2003
Perceived barriers Baseline, 3 and 6 mo. Obstacles that inhibit smoking cessation, α = .70. Menon et al. 2003
Self-efficacy for quitting Baseline, 3 and 6 mo. Smoking Abstinence Self-efficacy Scale, 4-items,
α = 85-.89
Tiffany and Drobes 1991
Stage of change Baseline, follow-ups Smoking Cessation Contemplation Ladder,
0–10 measure
Biener and Abrams 1991
Psychosocial factors
Perceived stress Baseline, 3 and 6 mo. Perceived Stress Scale, 14-items Cohen et al. 1983; Cohen
and Williamson 1988
# of stressful life events Baseline, 3 and 6 mo. The Scaling of Life Events Questionnaire, 61-items Paykel et al. 1971
Minority stress factors
Internalized homophobia Baseline Internalized Homophobia Scale, 9-items, α = .79 Herek et al. 1997
Sexual orientation concealment Baseline Level of Outness Scale, 3 items, α = .86 Bowen et al. 2006
Experience of discrimination Baseline Experiences of Discrimination Scale [EDS], 45 items,
α = .74.
Krieger et al. 2005
Stigma consciousness Baseline Modified Devaluation-Discrimination scale, 12-items,
α = .88
Link 1987; Link et al. 2001
Cultural factors
Cultural identification Baseline Level of involvement with the LGBT community,
10-items, α = .76
Bowen et al. 2006
Cultural salience Baseline To be developed for this study ---
Background characteristics
Demographics Baseline Age, education, gender, income, insurance,
sexual orientation, marital status and race
---
Depression Baseline Beck Depression Inventory, 20-items, α = .86 Beck et al. 1961
Nicotine dependency Baseline Fagerstrom Test for Nicotine Dependence,
6-items, α = .61
Heatherton et al. 1991
Illicit drug use Baseline Measures of illicit drug use -----
Alcohol use All time points Time Ling Follow Back, α = .76-.97,
Michigan Alcohol Screening
Sobell and Sobel 1995; Sobell et al.
1979; Hughes et al. 2003
Note: All Time Points = Baseline, Weekly during intervention, and 1, 3, 6, 12 month follow-up interviews.
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using both perceived stress (Cohen et al. 1983; Cohen
and Williamson 1988) and scaling of life events (Paykel
et al. 1971).Analytic plan
To test the effectiveness of the CTQ-CT program com-
pared to the CTQ standard program, we will fit a series of
regression models to determine independent predictors
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and prolonged abstinence) and to test the independent
effect of treatment condition at each wave of data collec-
tion. To address the question of efficacy over time, we
aim to conduct survival analyses (i.e., discrete-time and
continuous-time hazard models) to estimate hazard func-
tions (i.e., risk of relapse) and survivor functions (i.e.,
probability of sustained quitting), identify periods when
relapse is likely, and determine the shape of the hazard
function (whether the risk increases, decreases or remains
constant over the year of participation). To test both
hypotheses, we will first estimate correlations among
all measures of cultural and psychosocial processes,
psychosocial indicators of general stress, and minority
specific stressors. We will then fit covariance structure
models to the data to estimate the simultaneous relation-
ships among the variables and to test for both mediator
and/or moderator effects. Analyses for this aim are
conceptually depicted in Figure 1. In examining these
mechanisms we will employ established procedures for
the construction and assessment of product terms in
SEM (Jaccard and Wan 1996; Jöreskog and Yang 1996).
In addition, model fit will be compared across subgroups
(e.g., lesbians, bisexuals, gay men, and transgendered
participants) via multiple group SEMs and formal testing
of parameter equivalence using nested difference-of- χ2
tests (Byrne 1998; Hayduk 1987).
Discussion
This is the first randomized control trial to test the effi-
cacy of a group based and culturally tailored smoking
cessation intervention for LGBT participants. This trial
provides a number of significant contributions. First, the
CTQ-CT program builds on an established smoking ces-
sation intervention (CTQ) by incorporating a number of
cultural tailoring strategies (i.e., Kreuter et al. 2002). Sec-
ond, our approach is innovative in that the analytical
model takes into account both general and culturally
specific individually mediated predictors of smoking
cessation. This addresses a gap in the literature, as most
models fail to take into account or assess the role of
cultural factors as predictors to account for within-group
variability. Third, the strong methodological design of this
study allows us to isolate the effect of treatment group
while controlling for a number of other factors. Fourth,
we use biochemical verification of smoking status (i.e., CO
monitoring) in addition to self-report measures. Fifth,
we follow up with study participants over a period of
12 months to determine the effect of the CTQ and
CTQ-CT interventions over time.
While this study has a number of strengths and contrib-
utes to existing gaps in the literature, we also acknowledge
several limitations. The sample is drawn from Chicago,
and additional research should be conducted with LGBTcommunities in other geographic areas. Only participants
highly motivated to quit and smoking 4 or more days per
week with CO air expired reading of ≥8 are included in
the study. This sample may differ from participants who
are less motivated to quit or who smoke less frequently.
Overall, this research addresses a number of gaps in the
existing literature on culturally targeted smoking cessation
interventions and contributes a culturally-informed model
of cessation with a rigorous methodological design. Find-
ings have the potential to shape knowledge and future
research about health behavior change for specific pop-
ulations and reduce smoking-related health disparities
for LGBT communities.
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